Company Search:
Advanced Search
Sponsored Links
Orion Oyj Company Snapshot
Orion Oyj operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Orion Oyj with three other pharmaceutical manufacturers in Europe: Indivior Plc of the United Kingdom (2016 sales of £786.93 million [US$1.09 billion] of which 100% was Buprenorphine Based Drugs), Recordati SpA of Italy (1.15 billion Euro [US$1.41 billion] of which 84% was Pharmaceuticals), and Krka DD Novo Mesto which is based in Slovenia (1.17 billion Euro [US$1.44 billion] of which 63% was European Union).

Sales Analysis. During the year ended December of 2016, sales at Orion Oyj were 1.07 billion Euro (US$1.32 billion). This is an increase of 5.7% versus 2015, when the company's sales were 1.02 billion Euro. This was the fifth consecutive year of sales increases at Orion Oyj (and since 2011, sales have increased a total of 17%). Sales of Pharmaceuticals Business saw an increase of 6.4% in 2016, from 957.80 million Euro to 1.02 billion Euro. Not all segments of Orion Oyj experienced an increase in sales in 2016: sales of Diagnostica fell 5.2% to 54.80 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Orion Oyj
  Stock Performance Chart for Orion Oyj
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 30.90
(Figures in Euro)
1 Week -5.9%   13 Weeks 0.5%  
4 Weeks -18.4%   52 Weeks -28.4%  
Orion Oyj Key Data:
  Ticker: ORNBV Country: Finland
  Exchanges: HEL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,073,500,000
(Year Ending Jan 2017).
Employees: 3,469
  Currency: Euro Market Cap: 4,343,996,994
  Fiscal Yr Ends: December Shares Outstanding: 140,582,427
  Share Type: B Osake Closely Held Shares: 17,796,571
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.